文献速递心血管胸部外周血管CT

CT体成分分析对经导管主动脉瓣置换术后1年死亡率的预后价值

Prognostic value of CT body composition analysis for 1-year mortality after transcatheter aortic valve replacement.
PubMed 文献 · Eur Radiol · 2024-07-18

单中心连续纳入2016年6月至2021年12月408例TAVR患者,术前CT测量T4、T12、L3水平骨骼肌与皮下脂肪面积,Cox回归分析体成分与1年死亡率的关系,显示T12水平肌少症合并脂肪减少症是1年全因死亡的独立危险因素。

要点

  • 术前CT测量T12水平骨骼肌和皮下脂肪指数可用于TAVR患者1年全因死亡风险分层。
  • 肌少症合并脂肪减少症者1年累积死亡率26%,均无者8%,差异有统计学意义(p=0.002)。
  • T12水平体成分中肌少症合并脂肪减少症为1年死亡独立危险因素(HR 4.09,95%CI 2.01-8.35)。

核心结论

  • 术前CT在胸部水平评估的肌少症或脂肪减少症可能有助于TAVR患者1年全因死亡的风险分层。

研究设计与样本

  • 单中心连续纳入2016年6月至2021年12月接受TAVR的患者408例(男185例、女223例;平均年龄81.7±5.1岁,范围62-98岁),测量术前CT T4、T12、L3水平骨骼肌和皮下脂肪面积,采用Cox比例风险回归分析体成分与1年死亡率的关系。

关键影像表现/征象

  • L3水平肌肉-身高指数和脂肪-身高指数与T12水平的相关性(r=0.765,p<0.001和r=0.932,p<0.001)强于与T4水平的相关性(r=0.535,p<0.001和r=0.895,p<0.001)。

诊断标准与关键数值

  • 1年累积死亡率:肌少症合并脂肪减少症患者26%,仅脂肪减少症17%,仅肌少症12%,两者均无8%(p=0.002)。
  • 多因素分析显示T12水平体成分中肌少症合并脂肪减少症为1年死亡的独立危险因素(HR 4.09,95%CI 2.01-8.35,p<0.001)。

临床应用与阅片要点

  • 术前CT阅片时可测量T12水平骨骼肌和皮下脂肪面积,识别肌少症和脂肪减少症以辅助TAVR术后1年死亡风险分层。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To investigate the value of body composition indices derived from pre-procedural computed tomography (CT) in predicting 1-year mortality among patients who underwent transcatheter aortic valve replacement (TAVR).

MATERIALS AND METHODS: We assessed consecutive patients who underwent TAVR between June 2016 and December 2021 at a single academic medical center. Skeletal muscle and subcutaneous fat area at the T4, T12, and L3 levels on pre-procedural CT were measured. The association between body composition and 1-year mortality was evaluated using Cox proportional hazard regression analysis.

RESULTS: Finally, 408 patients were included (185 men and 223 women; mean age, 81.7 ± 5.1 years; range, 62-98 years). Post-procedural death occurred in 13.2% of patients. The muscle-height index and fat-height index at the L3 level were more strongly correlated with those at the T12 level (r = 0.765, p < 0.001 and r = 0.932, p < 0.001, respectively) than with those at the T4 level (r = 0.535, p < 0.001 and r = 0.895, p < 0.001, respectively). The cumulative 1-year mortality rate was highest for patients with both sarcopenia and adipopenia (26%), followed by those with adipopenia only (17%), those with sarcopenia only (12%), and those with neither sarcopenia nor adipopenia (8%, p = 0.002). Multivariable analysis revealed that body composition at the T12 level was an independent risk factor for 1-year mortality (hazard ratio: 4.09, 95% confidence interval: 2.01-8.35) in patients with both sarcopenia and adipopenia (p < 0.001).

CONCLUSION: Sarcopenia or adipopenia assessed with CT at the thoracic level may be valuable for stratifying 1-year all-cause mortality in patients who undergo TAVR.

CLINICAL RELEVANCE STATEMENT: Skeletal muscle and subcutaneous fat mass indices at the level of T12, measured on pre-procedural CT, have value for risk stratification of 1-year all-cause mortality in patients who undergo transcatheter aortic valve replacement.

KEY POINTS: Sarcopenia and adipopenia are associated with the prognosis of patients undergoing transcatheter aortic valve replacement. Body composition at the T12 level was an independent risk factor for 1-year all-cause mortality. Sarcopenia or adipopenia assessed at T12 with pre-procedural CT is valuable for risk stratification.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Soh S, Suh YJ, Lee S, et al. Prognostic value of CT body composition analysis for 1-year mortality after transcatheter aortic valve replacement. Eur Radiol. 2024. PMID: 39023558. doi:10.1007/s00330-024-10953-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。